Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Regulatory News (PRM)

Share Price Information for Proteome (PRM)

Share Price is delayed by 15 minutes
Get Live Data
1.61    0.205 (12.81%)
Bid:
1.61
Ask:
2.00
Spread: 0.39 (24.224%)
Market Cap: £5.65m
PRM Live PriceLast checked at - London Stock Exchange

Intraday Proteome Share Chart

Holding(s) in Company

1 Apr 2008 15:20

TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying Proteome Securities Plc issuer of existing shares to which voting

rights are attached:

2. Reason for the notification (please tick the appropriate box or

boxes) An acquisition or disposal of voting rights

Yes

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are

attached

An event changing the breakdown of voting rights 3. Full name of person(s) subject to the Cubana Investments Limited

notification obligation:

4. Full name of shareholder(s) (if different

from 3.):

5. Date of the transaction (and date on which 01 April 2008 the threshold is crossed or reached if

different):

6. Date on which issuer notified: 01 April 2008 7. Threshold(s) that is/are crossed or reached: >8%

8. Notified details:

A: Voting rights attached to shares

Class/type Situation previous Resulting situation after the triggering of shares to the Triggering transaction transaction if possible using the ISIN CODE Number of Number of Number of Number of voting % of voting Shares Voting shares rights rights Rights Direct Indirect Direct Indirect

GB0003104196 10,374,272 10,374,272 10,531,272 10,531,272 10,531,272

8.01% B: Financial Instruments

Resulting situation after the triggering transaction

Type of Expiration Exercise/ Number of voting % of voting financial date Conversion Period/ rights that may be rights instrument Date acquired if the instrument is exercised/ converted N/A N/A N/A N/A N/A Total (A+B) Number of voting rights % of voting rights 10,531,272 8.01

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

N/A Proxy Voting: 10. Name of the proxy holder: N/A

11. Number of voting rights proxy holder will N/A

cease to hold:

12. Date on which proxy holder will cease to hold N/A

voting rights: 13. Additional Information Contact name: James Malthouse Contact Telephone number: +44 1932 865065

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification Of Major Interests In Shares

A: Identity of the person or legal entity subject to the notification

obligation

Full name (including legal form for legal Cubana Investments Limited

entities) Contact address (registered office for PO Box 957, Offshore Incorporationslegal entities) Centre, Road Town, Tortola, British Virgin Islands

Other useful information (at least legal representative for legal persons) B: Identity of the notifier, if applicable

Full name Mirza Rahman Contact address 2 Battery Road, #26-01 Maybank Tower, Singapore 049907 Phone number +65 65381998 : msrahman@artradis.com

Other useful information (e.g. functional Compliance Officer relationship with the person or legal entity subject to the notification

obligation) C: Additional information

PROTEOME SCIENCES PLC
Date   Source Headline
26th May 20229:04 amRNSChange of Registered Office
16th May 20221:24 pmRNSResult of AGM
16th May 20227:00 amRNSAGM Statement
12th May 20227:00 amRNSSubstantial Contract Win
26th Apr 20224:45 pmRNSDirector/PDMR Shareholding
21st Apr 20225:13 pmRNSDirector/PDMR Shareholding
11th Apr 20227:00 amRNSInvestor Presentation
1st Apr 20226:01 pmRNSDirector shareholding
31st Mar 20227:09 amRNSFinal Results
30th Mar 202211:24 amRNSLoan amendment
29th Mar 20227:00 amRNSNotice of Results
16th Feb 20224:40 pmRNSSecond Price Monitoring Extn
16th Feb 20224:35 pmRNSPrice Monitoring Extension
3rd Feb 20227:00 amRNSTrading Update
31st Dec 202112:36 pmRNSPrice Monitoring Extension
20th Dec 20217:00 amRNSSubstantial Contract Win
9th Dec 20214:41 pmRNSSecond Price Monitoring Extn
9th Dec 20214:36 pmRNSPrice Monitoring Extension
29th Nov 20214:36 pmRNSPrice Monitoring Extension
26th Nov 20214:36 pmRNSPrice Monitoring Extension
5th Nov 20217:00 amRNSPRM,INmune Bio presenting biomarker discovery data
3rd Nov 20214:41 pmRNSSecond Price Monitoring Extn
3rd Nov 20214:36 pmRNSPrice Monitoring Extension
26th Aug 20214:40 pmRNSSecond Price Monitoring Extn
26th Aug 20214:36 pmRNSPrice Monitoring Extension
29th Jul 20217:00 amRNSInterim Results
15th Jul 20214:41 pmRNSSecond Price Monitoring Extn
15th Jul 20214:35 pmRNSPrice Monitoring Extension
18th Jun 20211:14 pmRNSLoan amendment
8th Jun 202112:54 pmRNSGrant of Options and PDMR/director shareholdings
19th May 20216:01 pmRNSIssuance of key TMT Patent
18th May 20219:48 amRNSChange of Registered Office
12th May 20214:36 pmRNSPrice Monitoring Extension
7th May 20214:41 pmRNSSecond Price Monitoring Extn
7th May 20214:36 pmRNSPrice Monitoring Extension
6th May 20214:41 pmRNSSecond Price Monitoring Extn
6th May 20214:35 pmRNSPrice Monitoring Extension
5th May 20214:41 pmRNSSecond Price Monitoring Extn
5th May 20214:35 pmRNSPrice Monitoring Extension
5th May 202111:57 amRNSResult of AGM
5th May 202111:00 amRNSAGM Statement
27th Apr 20214:40 pmRNSSecond Price Monitoring Extn
27th Apr 20214:35 pmRNSPrice Monitoring Extension
19th Apr 20215:25 pmRNSDirector/PDMR Shareholding
14th Apr 202112:18 pmRNSDirector/PDMR Shareholding
7th Apr 20214:40 pmRNSSecond Price Monitoring Extn
7th Apr 20214:35 pmRNSPrice Monitoring Extension
1st Apr 202112:48 pmRNSHolding(s) in Company
1st Apr 20219:34 amRNSInvestor Presentation
1st Apr 20217:40 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.